Comparison of Glucose Management Between Open‐Source Loop and Tandem Control‐ IQ Automated Insulin Delivery Systems in Adults With Type 1 Diabetes
Open Access
- 23 March 2026
- journal article
- research article
- Published by Wiley in Diabetes, Obesity and Metabolism
- Vol. 28 (6) , 5394-5398
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (148464)
This publication has 12 references indexed in Scilit:
- Use of High-Potency GLP-1 Receptor Agonists With OpenAPS Automated Insulin Dosing Algorithm Eliminates Need for Meal Announcements to Achieve Glycemic GoalsDiabetes Care, 2026
- Despite lower haemoglobin A1c with second‐generation automated insulin delivery systems, mental burden remains high for all adults with type 1 diabetes: A BETTER registry analysisDiabetes, Obesity and Metabolism, 2025
- Open-Source Versus Commercial Automated Insulin Delivery System for Type 1 Diabetes Management: A Prospective Observational Comparative Study from CanadaDiabetes Technology & Therapeutics, 2025
- Switching From Open-source to Commercial Advanced Automated Insulin Delivery System: Glucose Management and Patient Perspective in an Adult Living With Type 1 DiabetesCanadian Journal of Diabetes, 2024
- Retrospective Comparison of Commercially Available Automated Insulin Delivery With Open-Source Automated Insulin Delivery Systems in Type 1 DiabetesJournal of Diabetes Science and Technology, 2024
- Are all HCL systems the same? long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based studyFrontiers in Endocrinology, 2023
- Comparison of Control‐IQ and open‐source AndroidAPS automated insulin delivery systems in adults with type 1 diabetes: The CODIAC studyDiabetes, Obesity and Metabolism, 2023
- Consensus Recommendations for the Use of Automated Insulin Delivery Technologies in Clinical PracticeEndocrine Reviews, 2022
- Open-source automated insulin delivery: international consensus statement and practical guidance for health-care professionalsThe Lancet Diabetes & Endocrinology, 2021
- Use of a do-it-yourself artificial pancreas system is associated with better glucose management and higher quality of life among adults with type 1 diabetesTherapeutic Advances in Endocrinology and Metabolism, 2020